21 results
424B4
RNAZ
TransCode Therapeutics Inc
19 Jan 24
Prospectus supplement with pricing info
9:57pm
in clinical trials may not be indicative of results obtained when such trials are completed. There is typically an extremely high rate of attrition from
DRS
bjgqrl 35m6bpfsqa
29 Jul 22
Draft registration statement
12:00am
10-K
p6s3e2tf
31 Mar 22
Annual report
11:19am
10-Q
bppsvdwppz
23 Aug 21
Quarterly report
4:53pm
424B4
nwmri yxgaev
9 Jul 21
Prospectus supplement with pricing info
5:22pm
S-1
jmkzp1hjg9 e9kwyf48
26 Feb 21
IPO registration
4:06pm
DRS/A
nxmoy
27 Jan 21
Draft registration statement (amended)
12:00am